Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5189-11-7
2. Pizotyline Malate
3. Pizotifen (malate)
4. Pizotifen Hydrogen Malate
5. Pizotifenmalate
6. 99o99yvr4c
7. 4-(9,10-dihydro-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine 2-hydroxysuccinate
8. 5189-11-7 (malate)
9. Chebi:50213
10. Sanomigran
11. Nsc-758899
12. Bc-105 (malate);pizotyline (malate)
13. Sanomtgran
14. Sandomigran (tn)
15. Piperidine, 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methyl-, Malate (1:1)
16. Mosegor
17. Litec Malate
18. Sandomigran Malate
19. Sandomygran Malate
20. 4-(9,10-dihydro-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine Malate
21. Bc 105 Malate
22. Sr-05000001896
23. Einecs 225-970-4
24. Mosegor (tn)
25. Pizotyline (malate)
26. Bc-105 (malate)
27. Prestwick0_000992
28. Prestwick1_000992
29. Prestwick2_000992
30. Prestwick3_000992
31. Unii-99o99yvr4c
32. Bspbio_001083
33. Schembl365598
34. Spectrum1505003
35. Spbio_002974
36. Pizotyline Malate [mi]
37. Bpbio1_001193
38. Chembl1592663
39. Hy-b0115a
40. Dtxsid60966214
41. Pizotifen Malate [who-dd]
42. Hms1571g05
43. Hms2093g20
44. Hms2098g05
45. Hms3651c11
46. Hms3715g05
47. Hms3884m13
48. Pharmakon1600-01505003
49. Bcp21824
50. Mfcd01700978
51. Nsc758899
52. S1394
53. Akos015907762
54. Ccg-213329
55. Cs-1871
56. Nsc 758899
57. Ncgc00096062-01
58. Ncgc00096062-02
59. As-10171
60. Malic Acid, Compound With 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methylpiperidine (1:1)
61. Sw197333-4
62. C75436
63. D08397
64. Pizotyline Malate; Bc-105 Malate; Litec Malate
65. 189p117
66. Q-201591
67. Sr-05000001896-1
68. Sr-05000001896-3
69. Q27121986
70. 2-hydroxybutanedioic Acid--4-(9,10-dihydro-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine (1/1)
71. 2-hydroxybutanedioic Acid;1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine
72. 4-(9,10-dihydro-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine 2-hydroxybutanedioate
73. Butanedioic Acid, Hydroxy-, Compd. With 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methylpiperidine (1:1)
Molecular Weight | 429.5 g/mol |
---|---|
Molecular Formula | C23H27NO5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 429.16099414 g/mol |
Monoisotopic Mass | 429.16099414 g/mol |
Topological Polar Surface Area | 126 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 535 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Market Place
ANALYTICAL
ABOUT THIS PAGE
51
PharmaCompass offers a list of Pizotifen Malate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pizotifen Malate manufacturer or Pizotifen Malate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pizotifen Malate manufacturer or Pizotifen Malate supplier.
PharmaCompass also assists you with knowing the Pizotifen Malate API Price utilized in the formulation of products. Pizotifen Malate API Price is not always fixed or binding as the Pizotifen Malate Price is obtained through a variety of data sources. The Pizotifen Malate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mosegor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mosegor, including repackagers and relabelers. The FDA regulates Mosegor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mosegor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mosegor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mosegor supplier is an individual or a company that provides Mosegor active pharmaceutical ingredient (API) or Mosegor finished formulations upon request. The Mosegor suppliers may include Mosegor API manufacturers, exporters, distributors and traders.
click here to find a list of Mosegor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Mosegor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mosegor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mosegor GMP manufacturer or Mosegor GMP API supplier for your needs.
A Mosegor CoA (Certificate of Analysis) is a formal document that attests to Mosegor's compliance with Mosegor specifications and serves as a tool for batch-level quality control.
Mosegor CoA mostly includes findings from lab analyses of a specific batch. For each Mosegor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mosegor may be tested according to a variety of international standards, such as European Pharmacopoeia (Mosegor EP), Mosegor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mosegor USP).